POINT Biopharma Global (PNT) Q1 2023 Earnings

15MayConfirmed
May 22
Aug 22
Nov 22
Q1 2023
-0.31
-0.26
-0.21
-0.16

Details

Expected EPS
-0.31
Actual EPS
-0.16
Surprise EPS
0.15
Surprise Percent
+48.39%

Description

POINT Biopharma Global (PNT) has reported earnings of -0.16 per share for Q1 2023.

0 Comments

Share your thoughts